⌘K

Home/Filings/4/0001405626-19-000001

4//SEC Filing

Corin Denis 4

Accession 0001405626-19-000001

CIK 0001596062other

View on SEC.gov Company Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:41 PM ET

Size

9.5 KB

Accession

0001405626-19-000001

Insider Transaction Report

Form 4

Period: 2018-07-12

Q BioMed Inc.QBIO

DirectorChief Executive Officer10% Owner

Transactions

Sale
Common Stock
2018-07-12$2.11/sh−6,400$13,530→ 2,435,400 total
Award
Incentive Stock Options
2019-06-05+100,000→ 950,000 total
Exercise: $1.25Exp: 2024-06-05→ Common Stock (100,000 underlying)
Award
Incentive Stock Options
2019-06-05+50,000→ 850,000 total
Exercise: $1.25Exp: 2024-06-05→ Common Stock (50,000 underlying)

Footnotes (4)

[F1]These options vest in 4 equal installments of 12,500 each, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The first installment vested on June 5, 2019.
[F2]Issued for director services.
[F3]These options vest in 4 equal installments of 25,000 each, subject to the Reporting Person's continuous service to the Issuer through each vesting date. The first installment vested on June 5, 2019.
[F4]Issued for officer services.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Q BioMed Inc.

CIK 0001596062

Entity typeother

Related Parties

1

filerCIK 0001405626

Filing Metadata

Form type: 4
Filed: Nov 5, 7:00 PM ET
Accepted: Nov 6, 5:41 PM ET
Size: 9.5 KB

View on SEC.gov